Cystatin C/albumin ratio for early diagnosis of esophageal varices in liver cirrhosis
Open Access
- 28 June 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (26) , e38481
Abstract
The mortality rate related to variceal bleeding is high in patients with liver cirrhosis. Early detection and treatment of varices can reduce the risk of hemorrhage and thus decrease the mortality rate related to variceal bleeding. The study comprised 81 cirrhotic patients in training set, who were categorized into 2 groups: the patients with esophageal varices (EVs group) and the patients without esophageal varices (non-EVs group). The disparity in Cystatin C/albumin ratio (CAR) was assessed between these 2 groups. Subsequently, a regression model was constructed by generating a receiver operating characteristic (ROC) curve to calculate the area under the curve (AUC). Then an external validation was performed in 25 patients. Among patients with cirrhosis in training set, a statistically significant difference in CAR was observed between the EVs group and non-EVs group ( P < .05). At the CAR cutoff value of 2.79*10 −5 , the AUC for diagnosing EVs were 0.666. Further, a multivariate logistic regression model was constructed, after adjusting the model, the AUC for EVs diagnosis were 0.855. And the external validation showed that the model could not be considered as a poor fit. CAR exhibits potential as an early detection marker for EVs in liver cirrhosis, and the regression model incorporating CAR demonstrates a strong capability for early EVs diagnosis.Keywords
This publication has 18 references indexed in Scilit:
- Neutrophil gelatinase‐associated lipocalin and cystatin C in cirrhosis and portal hypertension: Relations to organ extraction and dysfunctionJournal of Gastroenterology and Hepatology, 2017
- Portal hypertensive bleeding in cirrhosisHepatology, 2017
- Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic databaseGastrointestinal Endoscopy, 2007
- Relationship between matrix metalloproteinase-2 activity and cystatin C levels in patients with hepatic diseaseClinical Biochemistry, 2005
- Cystatin C as a marker of GFR—history, indications, and future researchClinical Biochemistry, 2005
- Increased cystatin C serum concentrations in patients with hepatic diseases of various severitiesClinica Chimica Acta, 2004
- Incidence and natural history of small esophageal varices in cirrhotic patientsJournal of Hepatology, 2003
- Elevation of serum cystatin C concentrations in patients with chronic liver diseaseEuropean Journal of Gastroenterology & Hepatology, 2001
- Cystatin C-Properties and use as diagnostic marker2001
- Prediction of the First Variceal Hemorrhage in Patients with Cirrhosis of the Liver and Esophageal VaricesNew England Journal of Medicine, 1988